Update
$Ocugen (OCGN.US)$ Reuters· 3 mins ago
Ocugen, Inc. Announces FDA Approval of Expanded Access Program for Patients With Retinitis Pigmentosa
Ocugen, Inc. Announces FDA Approval of Expanded Access Program for Patients With Retinitis Pigmentosa
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
